YJ7-33841-01089
2 vaccinations
3 coded responses
19 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 774 / TX
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-18
Registered in v-safe
-
2020-12-18
Dose 1 — Pfizer-BioNTech
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-27
-
2021-01-03
Survey response — day 14, dose 1MedDRA: Ageusia, Anosmia, Fatigue, Nasal congestion — Feeling: Good · Be unable to workFree text: Nasal congestion, loss of smell/taste, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-03
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body achesAdult check-in
- 2021-01-10
- 2021-01-14
- 2021-01-17
- 2021-01-22
- 2021-01-29
- 2021-02-13
- 2021-02-19
- 2021-04-11
-
2021-07-09
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: PregnancyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-09
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-27
-
2022-01-10
Survey response — 12 months, dose 2MedDRA: Gestational hypertension, Pre-eclampsia — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, HospitalizationFree text: Pregnancy induced hypertension PreeclampsiaMedDRA releases: 2024-11 · check-in free text available
-
2022-01-10
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2022-01-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-18 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-03 | priority 2/3 | |
| 2021-07-09 | Unsuccessful | |
| 2022-01-10 | Unsuccessful |
Free text
Release 1 — day 14, dose 1
Symptoms: Nasal congestion, loss of smell/taste, fatigue
Release 9 — 6 months, dose 2
Symptoms: Pregnancy
Release 10 — 12 months, dose 2
Symptoms: Pregnancy induced hypertension Preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gestational hypertension | · | · | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Pre-eclampsia | · | · | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release